Screener
Halozyme Therapeutics HALO Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Halozyme Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Halozyme Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001159036-26-000104
FAQ
- What is Halozyme Therapeutics's price / sales?
- Halozyme Therapeutics (HALO) reported price / sales of 5.6× in Q2 2026.
- How has Halozyme Therapeutics's price / sales changed year-over-year?
- Halozyme Therapeutics's price / sales decreased by 1.0% year-over-year, from 5.6× to 5.6×.
- What is the long-term trend for Halozyme Therapeutics's price / sales?
- Over 5 years (2020 to 2025), Halozyme Therapeutics's price / sales has grown at a -23.8% compound annual growth rate (CAGR), from 22× to 5.7×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Halozyme Therapeutics's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude